nach oben

Forensic Toxicology

Erschienen in:

01.01.2019 | Letter to the Editor

Use of polysaccharide-based chiral columns: enantiomeric separation of seven pairs of abused drugs by high-performance liquid chromatography–mass spectrometry

verfasst von: Tajudheen K. Karatt, Abdul Khader Karakka Kal, Ramy Sayed, Jahfar Nalakath, Zubair Perwad

Erschienen in: Forensic Toxicology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor …

The International Federation for Equestrian Sports (2018) The FEI equine prohibited substances database. http://prohibitedsubstancesdatabase.feicleansport.org/search. Accessed 6 Aug 2018

The United States Pharmacopeial Convention (2008) Corticosteroids—glucocorticoid effects (veterinary-systemic). https://cdn.ymaws.com/www.aavpt.org/resource/resmgr/imported/corticosteroids2008.pdf. Accessed 6 Aug 2018

Gibson T, Burry HC, Poswillo D, Glass J (1977) Effect of intra-articular corticosteroid injections on primate cartilage. Ann Rheum Dis 36:74–79CrossRefPubMedPubMedCentral

Evans NA (2004) Current concepts in anabolic-androgenic steroids. Am J Sports Med 32:534–542CrossRefPubMed

Kuhn CM (2002) Anabolic steroids. Recent Prog Horm Res 57:411–434CrossRefPubMed

Craig CR, Stitzel RE (2004) Modern pharmacology with clinical applications, 6th edn. Lippincott Williams & Wilkins, Philadelphia

Godwin M, Dawes M (2004) Intra-articular steroid injections for painful knees. Systematic review with meta-analysis. Can Fam Physician 50:241–248PubMedPubMedCentral

Breyer J, Jacobson HR (1990) Molecular mechanisms of diuretic agents. Annu Rev Med 41:265–275CrossRefPubMed

Brater DC (1983) Pharmacodynamic considerations in the use of diuretics. Annu Rev Pharmacol Toxicol 23:45–62CrossRefPubMed

10.

Goyal RK, Hirano I (1996) Mechanisms of disease: the enteric nervous system. N Engl J Med 334:1106–1115CrossRefPubMed

11.

Majewski H (1983) Modulation of noradrenaline release through activation of presynaptic β-adrenoreceptors. J Auton Pharmacol 3:47–60CrossRefPubMed

12.

Davis E, Loiacono R, Summers RJ (2009) The rush to adrenaline: drugs in sport acting on the β-adrenergic system. Br J Pharmacol 154:584–597CrossRef

13.

Franchimont P, Gaspard U, Reuter A, Heynen G (1972) Polymorphism of protein and polypeptide hormones. Clin Endocrinol 4:315–336CrossRef

14.

Ali I, Gupta VK, Aboul-Enein HY, Singh P, Sharma B (2007) Role of racemization in optically active drugs development. Chirality 19:453–463CrossRefPubMed

15.

Adams J (1993) Structure–activity and dose–response relationships in the neural and behavioral teratogenesis of retinoids. Neurotoxicol Teratol 15:193–202CrossRefPubMed

16.

Agranat I, Caner H, Caldwell J (2002) Putting chirality to work: the strategy of chiral switches. Nat Rev Drug Discov 1:753–768CrossRefPubMed

17.

Andrews JE, Ebron-McCoy M, Bojic U, Nau H, Kavlock RJ (1995) Validation of an in vitro teratology system using chiral substances: stereo selective teratogenicity of 4-yn-valproic acid in cultured mouse embryos. Toxicol Appl Pharmacol 132:310–316CrossRefPubMed

18.

Anonymous (1997) Fenfluramine and dexfenfluramine withdrawn from market. Am J Health Syst Pharm 54:2260–2269

19.

Oh SS, Hess O (2015) Chiral metamaterials: enhancement and control of optical activity and circular dichroism. Nano Converg 2:24. https://doi.org/10.1186/s40580-015-0058-2 CrossRefPubMedPubMedCentral

20.

Cahn RS, Ingold C, Prelog V (1956) The specification of asymmetric configuration in organic chemistry. Experientia 12:81–94CrossRef

21.

Smith SW (2009) Chiral toxicology: it’s the same thing…only different. Toxicol Sci 110:4–30CrossRefPubMed

22.

Tripathi K (1993) Drug enantiomers and their pharmacological implications. Ind J Pharmacol 25:73–77

23.

Porter WH (1991) Resolution of chiral drugs. Pure Appl Chem 63:1119–1122CrossRef

24.

Burke D, Henderson DJ (2002) Chirality: a blueprint for the future. Br J Anaesth 88:563–576CrossRefPubMed

25.

Ariens EJ (1984) Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol 26:663–668CrossRefPubMed

26.

Ribeiro C, Santos C, Gonçalves V, Ramos A, Afonso C, Tiritan ME (2018) Chiral drug analysis in forensic chemistry: an overview. Molecules 23:262. https://doi.org/10.3390/molecules23020262 CrossRefPubMedCentral

27.

Taschwer M, Grascher J, Schmid MG (2016) Development of an enantioseparation method for novel psychoactive drugs by HPLC using a Lux^® Cellulose-2 column in polar organic phase mode. Forensic Sci Int 270:232–240CrossRefPubMed

28.

Hegstad S, Havnen H, Helland A, Spigset O, Frost J (2018) Enantiomeric separation and quantification of R/S-amphetamine in urine by ultra-high performance supercritical fluid chromatography tandem mass spectrometry. J Chromatogr B 1077-1078:7–12CrossRef

29.

Doi T, Tagami T, Takeda A, Asada A, Sawabe Y (2018) Evaluation of carboxamide-type synthetic cannabinoids as CB₁/CB₂ receptor agonists: difference between the enantiomers. Forensic Toxicol 36:51–60CrossRefPubMed

30.

Karatt TK, Nalakath J, Perwad Z, Albert PH, Khader KKA, Padusha MSA, Laya S (2018) Mass spectrometric method for distinguishing isomers of dexamethasone via fragment mass ratio: an HRMS approach. J Mass Spectrom 53:1046–1058CrossRefPubMed

31.

Peng L, Jayapalan S, Chankvetadze B, Farkas T (2010) Reversed-phase chiral HPLC and LC/MS analysis with tris(chloromethylphenylcarbamate) derivatives of cellulose and amylose as chiral stationary phases. J Chromatogr A 1217:6942–6955CrossRefPubMed

32.

Tachibana K, Ohnishi A (2001) Reversed-phase liquid chromatographic separation of enantiomers on polysaccharide type chiral stationary phases. J Chromatogr A 906:127–154CrossRefPubMed

33.

Karatt TK, Sayed R, Nalakath J, Perwad Z, Albert PH, Abdul Khader KK (2018) Separation and identification of the epimeric doping agents—dexamethasone and betamethasone in equine urine and plasma: a reversed phase chiral chromatographic approach. Steroids 140:77–82CrossRefPubMed

34.

Barhate CL, Wahab MF, Breitbach ZS, Bell DS, Armstrong DW (2015) High efficiency, narrow particle size distribution, sub-2 μm based macrocyclic glycopeptide chiral stationary phases in HPLC and SFC. Anal Chim Acta 898:128–137CrossRefPubMed

35.

Dolzan MD, Shu Y, Smuts JP, Petersen H, Ellegaard P, Micke GA, Armstrong DW, Breitbach ZS (2016) Enantiomeric separation of citalopram analogues by HPLC using macrocyclic glycopeptide and cyclodextrin based chiral stationary phases. J Liq Chromatogr Relat Technol 39:154–160CrossRef

36.

Kosel M, Eap CB, Amey M, Baumann P (1998) Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography. J Chromatogr B 719:234–238CrossRef

37.

Matthijs N, Perrin C, Maftouh M, Massart DL, Vander Heyden Y (2004) Definition and system implementation of strategies for method development of chiral separations in normal-or reversed-phase liquid chromatography using polysaccharide-based stationary phases. J Chromatogr A 1041:119–133CrossRefPubMed

38.

Padivitage NL, Dodbiba E, Breitbach ZS, Armstrong DW (2014) Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases. Drug Test Anal 6:542–551CrossRefPubMed

39.

Geryk R, Kalíková K, Vozka J, Tesarˇová E (2013) Immobilized polysaccharide-based stationary phases for enantioseparation in normal versus reversed phase HPLC. Chromatographia 76:483–489CrossRef

40.

USP (1978) The United States Pharmacopeia, 20th revision. The United States Pharmacopeia, Washington, DC, p 943

41.

Perrin C, Vu VA, Matthijs N, Maftouh M, Massart DL, Vander Heyden Y (2002) Screening approach for chiral separation of pharmaceuticals: Part I. Normal-phase liquid chromatography. J Chromatogr A 947:69–83CrossRefPubMed

Titel: Use of polysaccharide-based chiral columns: enantiomeric separation of seven pairs of abused drugs by high-performance liquid chromatography–mass spectrometry
verfasst von: Tajudheen K. Karatt
Abdul Khader Karakka Kal
Ramy Sayed
Jahfar Nalakath
Zubair Perwad
Publikationsdatum: 01.01.2019
Verlag: Springer Japan
Erschienen in: Forensic Toxicology / Ausgabe 1/2019
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI: https://doi.org/10.1007/s11419-018-0453-6

Neu im Fachgebiet Rechtsmedizin

01.04.2024 | Forensische Traumatologie | CME

Springer Medizin

Use of polysaccharide-based chiral columns: enantiomeric separation of seven pairs of abused drugs by high-performance liquid chromatography–mass spectrometry

Excerpt

Neu im Fachgebiet Rechtsmedizin

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

NBOMe instability in whole blood

MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity

Crystal structures and other properties of ephedrone (methcathinone) hydrochloride, N-acetylephedrine and N-acetylephedrone

Simultaneous chiral impurity analysis of methamphetamine and its precursors by supercritical fluid chromatography–tandem mass spectrometry

Effects of exposure to 5-MeO-DIPT during adolescence on brain neurotransmission and neurotoxicity in adult rats

Postmortem detection of rocuronium and sugammadex by LC/MS in the blood of a patient who died on postoperative day 8

Neu im Fachgebiet Rechtsmedizin

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien